Supplement firms face injunction for health claims
This article was originally published in The Tan Sheet
FDA announces a permanent injunction against Brownwood Acres Foods and Cherry Capital Services, and two of their executives as a result of unapproved drug claims and unauthorized health claims about their products, which include liquid glucosamine and salmon oil capsules, agency reports Feb. 22. According to FDA, the firms and executives agreed to a consent decree that prohibits them from manufacturing and distributing products claimed to "cure, treat, mitigate or prevent diseases." Signed by a U.S. District Court in Michigan, the decree requires the firms to remove the claims from the labels of products, Web sites and brochures, and hire an expert to review claims. FDA notes firms cannot make such claims until products "are approved by the FDA as new drugs, exempt from approval as investigational new drugs, or until the claims on the products' label ... comply with the law"...
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.